Extensive contacts between ADAMTS13 exosites and von Willebrand factor domain A2 contribute to substrate specificity.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Blood

• Publication date

  2008-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2008-04-148759PMID 18492952PMCID PMC2518881
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Functional Differences of the Catalytic and Non-catalytic Domains in Human ADAMTS-4 and ADAMTS-5 in Aggrecanolytic Activity*

  2008cited by this paper
• Platelet-VWF complexes are preferred substrates of ADAMTS13 under fluid shear stress.

  2008cited by this paper
• Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5

  2008cited by this paper
• Factor XI/ADAMTS13 complexes are quantitatively insignificant in human plasma.

  2007cited by this paper
• An IAP retrotransposon in the mouse ADAMTS13 gene creates ADAMTS13 variant proteins that are less effective in cleaving von Willebrand factor multimers.

  2007cited by this paper
• Conformational stability and domain unfolding of the Von Willebrand factor A domains.

  2007cited by this paper
• The cooperative activity between the carboxyl-terminal TSP1 repeats and the CUB domains of ADAMTS13 is crucial for recognition of von Willebrand factor under flow.

  2007cited by this paper
• The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling

  2006cited by this paper
• Zinc and Calcium Ions Cooperatively Modulate ADAMTS13 Activity*

  2006cited by this paper
• Characterization of a core binding site for ADAMTS-13 in the A2 domain of von Willebrand factor

  2006influential reference
• Exosite interactions contribute to tension-induced cleavage of von Willebrand factor by the antithrombotic ADAMTS13 metalloprotease

  2006influential reference
• ADAMTS13 Substrate Recognition of von Willebrand Factor A2 Domain*

  2006influential reference
• Impact of mutations in the von Willebrand factor A2 domain on ADAMTS13-dependent proteolysis.

  2006cited by this paper
• The Proximal Carboxyl-terminal Domains of ADAMTS13 Determine Substrate Specificity and Are All Required for Cleavage of von Willebrand Factor*

  2005cited by this paper
• Binding of ADAMTS13 to von Willebrand Factor*

  2005cited by this paper
• FRETS‐VWF73, a first fluorogenic substrate for ADAMTS13 assay

  2005cited by this paper
• New concepts in von Willebrand disease.

  2005cited by this paper
• Molecular modeling of the von Willebrand factor A2 Domain and the effects of associated type 2A von Willebrand disease mutations

  2004cited by this paper
• Binding of platelet glycoprotein Ibalpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13.

  2004cited by this paper
• Recent advances in thrombotic thrombocytopenic purpura.

  2004cited by this paper
• VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13.

  2004cited by this paper
• An enzyme immunoassay of ADAMTS13 distinguishes patients with thrombotic thrombocytopenic purpura from normal individuals and carriers of ADAMTS13 mutations

  2004cited by this paper
• Cleavage of von Willebrand Factor Requires the Spacer Domain of the Metalloprotease ADAMTS13*

  2003cited by this paper
• ADAMTS-13 cysteine-rich/spacer domains are functionally essential for von Willebrand factor cleavage.

  2003cited by this paper
• Cleavage of the ADAMTS13 Propeptide Is Not Required for Protease Activity*

  2003cited by this paper
• Autocatalytic Cleavage of ADAMTS-4 (Aggrecanase-1) Reveals Multiple Glycosaminoglycan-binding Sites*

  2002cited by this paper
• A novel human metalloprotease synthesized in the liver and secreted into the blood: possibly, the von Willebrand factor-cleaving protease?

  2001cited by this paper
• Structure of von Willebrand Factor-cleaving Protease (ADAMTS13), a Metalloprotease Involved in Thrombotic Thrombocytopenic Purpura*

  2001cited by this paper
• Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura

  2001cited by this paper
• The Thrombospondin Motif of Aggrecanase-1 (ADAMTS-4) Is Critical for Aggrecan Substrate Recognition and Cleavage*

  2000cited by this paper
• Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.

  1998cited by this paper
• von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.

  1998cited by this paper
• Gene Defects in 150 Unrelated French Cases with Type 2 von Willebrand Disease: from the Patient to the Gene

  1997cited by this paper
• Two new candidate mutations in type IIA von Willebrand's disease (ARG834→GLY, GLY846→ARG) and one polymorphism (TYR821→CYS) in the A2 region of the von Willebrand factor

  1993cited by this paper
• Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations.

  1992cited by this paper
• Amino acid sequence of human von Willebrand factor.

  1986cited by this paper
• On the size of the active site in proteases. I. Papain.

  1967cited by this paper

• Beyond HELLP: An Unusual Cause of Severe Thrombocytopenia in Pregnancy

  2026cites this paper
• Zinc-Dependent Prothrombin Activator from Rhabdophis tigrinus Venom with Extended Substrate Specificity.

  2026cites this paper
• A Disintegrin and Metalloprotease with Thrombospondin Motif, Member 13, and Von Willebrand Factor in Relation to the Duality of Preeclampsia and HIV Infection

  2025cites this paper
• Mechanism underlying severe deficiency of plasma ADAMTS13 activity in immune thrombotic thrombocytopenic purpura.

  2024cites this paper
• Frontiers in pathophysiology and management of thrombotic thrombocytopenic purpura

  2023cites this paper
• Metalloprotease domain latency protects ADAMTS13 against broad- spectrum inhibitors of metalloproteases while maintaining activity towards VWF.

  2023cites this paper
• Mechanisms of Inhibition of Human Monoclonal Antibodies in Immune Thrombotic Thrombocytopenic Purpura.

  2023cites this paper
• A British Society for Haematology Guideline: Diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies

  2023cites this paper
• Mechanisms of ADAMTS13 regulation

  2022cites this paper
• A novel mechanism underlying allosteric regulation of ADAMTS-13 revealed by hydrogen−deuterium exchange plus mass spectrometry

  2022cites this paper
• Type 2A and 2M von Willebrand Disease: Differences in Phenotypic Parameters According to the Affected Domain by Disease-Causing Variants and Assessment of Pathophysiological Mechanisms

  2021cites this paper
• A human monoclonal antibody against the distal carboxyl terminus of ADAMTS‐13 modulates its susceptibility to an inhibitor in thrombotic thrombocytopenic purpura

  2021cites this paper
• An integrative structural biology analysis of von Willebrand factor binding and processing by ADAMTS-13 in solution.

  2021cites this paper
• Assessing thrombogenesis and treatment response in congenital thrombotic thrombocytopenic purpura

  2021cites this paper
• Dynamic changes in platelets caused by shear stress in aortic valve stenosis

  2020cites this paper
• Successful treatment of plasma exchange-refractory thrombotic thrombocytopenic purpura with rituximab: A case report

  2020cites this paper
• The Multifaceted Function of Granzymes in Sepsis: Some Facts and a Lot to Discover

  2020cites this paper
• Traumatic injury results in prolonged circulation of ultralarge von Willebrand factor and a reduction in ADAMTS13 activity

  2020cites this paper
• Tryptophan 387 and 390 residues in ADAMTS13 are crucial to the ability of vascular tube formation and cell migration of endothelial cells

  2020cites this paper
• ADAMTS proteases in cardiovascular physiology and disease

  2020cites this paper
• Domain-specific mechanical modulation of VWF–ADAMTS13 interaction

  2019cites this paper
• Phylogenetic and functional analysis of ADAMTS13 identifies highly conserved domains essential for allosteric regulation.

  2019cites this paper
• Exploring the "minimal" structure of a functional ADAMTS13 by mutagenesis and small-angle X-ray scattering.

  2019cites this paper
• METALLOPROTEASE ADAMTS-13

  2019cites this paper
• Crystal structure and substrate-induced activation of ADAMTS13

  2019cites this paper
• Exosites in Hypervariable Loops of ADAMTS Spacer Domains control Substrate Recognition and Proteolysis

  2019cites this paper
• High throughput protease profiling comprehensively defines active site specificity for thrombin and ADAMTS13

  2018cites this paper
• Prediction of spacer-α6 complex: a novel insight into binding of ADAMTS13 with A2 domain of von Willebrand factor under forces

  2018cites this paper
• ADAMTS13: origins, applications, and prospects

  2018cites this paper
• Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers

  2018influential citation
• Contemporary Reviews in Interventional Cardiology Cardiovascular Devices and Platelet Interactions Understanding the Role of Injury, Flow, and Cellular Responses

  2017cites this paper
• Interaction between the metalloprotease ADAMTS-13 and the proteins of the alternative pathway of the complement system

  2017cites this paper
• The effect of single nucleotide polymorphisms and mutations on congenital thrombotic thrombocytopenic purpura phenotype

  2017influential citation
• A novel monoclonal antibody against the von Willebrand Factor A2 domain reduces its cleavage by ADAMTS13

  2017cites this paper
• ADAMTS‐13 and von Willebrand factor: a dynamic duo

  2017cites this paper
• ADAM and ADAMTS Family Proteins and Snake Venom Metalloproteinases: A Structural Overview

  2016cites this paper
• Title : Degradation of two novel congenital TTP ADAMTS 13 mutants by the cell proteasome prevents ADAMTS 13 secretion

  2016cites this paper
• Conformational quiescence of ADAMTS‐13 prevents proteolytic promiscuity

  2016cites this paper
• Human neutrophil peptides inhibit cleavage of von Willebrand factor by ADAMTS13: a potential link of inflammation to TTP.

  2016cites this paper
• Degradation of two novel congenital TTP ADAMTS13 mutants by the cell proteasome prevents ADAMTS13 secretion.

  2016cites this paper
• THROMBOSIS AND HEMOSTASIS Human neutrophil peptides inhibit cleavage of von Willebrand factor by ADAMTS 13 : a potential link of in fl ammation to TTP

  2016cites this paper
• Von Willebrand Factor and ADAMTS13 in Cardiovascular Disease

  2016cites this paper
• The role of antibodies in acquired thrombotic thrombocytopenic purpura

  2016influential citation
• Identification and characterization of the elusive mutation causing the historical von Willebrand Disease type IIC Miami

  2016cites this paper
• High-resolution epitope mapping by HX MS reveals the pathogenic mechanism and a possible therapy for autoimmune TTP syndrome

  2015cites this paper
• Massively parallel enzyme kinetics reveals the substrate recognition landscape of the metalloprotease ADAMTS13

  2015cites this paper
• Probing ADAMTS13 Substrate Specificity using Phage Display

  2015cites this paper
• The co-influence of VWD type 2B/2M mutations in the A1 domain and platelet GPIbα on the rate of cleavage to VWF by ADAMTS13.

  2015cites this paper
• Platelets and physics: How platelets "feel" and respond to their mechanical microenvironment.

  2015cites this paper
• The role of the ADAMTS13 cysteine-rich domain in VWF binding and proteolysis.

  2015influential citation
• ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura.

  2015cites this paper
• THROMBOSIS AND HEMOSTASIS The role of the ADAMTS 13 cysteine-rich domain in VWF binding and proteolysis

  2015influential citation
• ADAMTS13: Structure and Function

  2015cites this paper
• ADAMTS13 and von Willebrand factor interactions

  2015cites this paper
• Conformational activation of ADAMTS13 Short title for RSS feed Conformational activation of ADAMTS13 Author affiliation

  2015cites this paper
• Carboxyl Terminus of ADAMTS13 Directly Inhibits Platelet Aggregation and Ultra Large von Willebrand Factor String Formation Under Flow in a Free-Thiol–Dependent Manner

  2014cites this paper
• Allosteric activation of ADAMTS13 by von Willebrand factor

  2014influential citation
• Potential value of targeting von Willebrand factor in atherosclerotic cardiovascular disease

  2014influential citation
• Von Willebrand factor and ADAMTS13 in arterial thrombosis: a systematic review and meta-analysis.

  2014cites this paper
• Hypochlorous Acid Generated by Neutrophils Inactivates ADAMTS13

  2014cites this paper
• Platelet-free shear flow assay facilitates analysis of shear-dependent functions of VWF and ADAMTS13.

  2014cites this paper
• Conformational activation of ADAMTS13

  2014cites this paper
• Structure–function and regulation of ADAMTS‐13 protease

  2013cites this paper
• Solution structure of the factor VIII binding region on von Willebrand factor

  2013cites this paper
• The WXXW motif in the TSR1 of ADAMTS13 is important for its secretion and proteolytic activity.

  2013cites this paper
• C2362F mutation gives rise to an ADAMTS13-resistant von Willebrand factor

  2013influential citation
• ADAMTS13: von Willebrand Factor-Cleaving Protease

  2013cites this paper
• Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.

  2012cites this paper
• Structural Basis of Type 2A von Willebrand Disease Investigated by Molecular Dynamics Simulations and Experiments

  2012cites this paper
• Snake venom metalloproteinases: structure, function and relevance to the mammalian ADAM/ADAMTS family proteins.

  2012cites this paper
• "ADAMTS13-RELATED ASSAYS IN ACQUIRED THROMBOTIC

  2012cites this paper
• Binding of von Willebrand factor cleaving protease ADAMTS13 to Lys-plasmin(ogen).

  2012cites this paper
• Rearranging Exosites in Noncatalytic Domains Can Redirect the Substrate Specificity of ADAMTS Proteases*

  2012cites this paper
• Calcium modulates force sensing by the von Willebrand factor A2 domain

  2011cites this paper
• Residues Arg568 and Phe592 contribute to an antigenic surface for anti-ADAMTS13 antibodies in the spacer domain

  2011cites this paper
• A novel calcium-binding site of von Willebrand factor A2 domain regulates its cleavage by ADAMTS13.

  2011cites this paper
• Essential Domains of A Disintegrin and Metalloprotease With Thrombospondin Type 1 Repeats-13 Metalloprotease Required for Modulation of Arterial Thrombosis

  2011cites this paper
• Cleavage of von Willebrand Factor by Granzyme M Destroys Its Factor VIII Binding Capacity

  2011cites this paper
• Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor.

  2011cites this paper
• Mechanism of von Willebrand factor scissile bond cleavage by a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13)

  2011cites this paper
• its cleavage by ADAMTS13 A novel calcium-binding site of von Willebrand factor A2 domain regulates

  2011cites this paper
• Biology and physics of von Willebrand factor concatamers

  2011cites this paper
• The distal carboxyterminal domains of murine ADAMTS13 influence proteolysis of platelet‐decorated VWF strings in vivo

  2010cites this paper
• ADAMTS‐13: double trouble for von Willebrand factor

  2010cites this paper
• Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents

  2010cites this paper
• Thrombospondin-1 and ADAMTS13 competitively bind to VWF A2 and A3 domains in vitro.

  2010cites this paper
• The Influence of Sequence Variation on von Willebrand Factor Biosynthesis, Proteolytic Processing and Clearance

  2010cites this paper
• Amino acid residues Arg 659 , Arg 660 , and Tyr 661 in the spacer domain of ADAMTS 13 are critical for cleavage of von Willebrand factor

  2010cites this paper
• A model for single-substrate trimolecular enzymatic kinetics.

  2010cites this paper
• Amino acid residues Arg(659), Arg(660), and Tyr(661) in the spacer domain of ADAMTS13 are critical for cleavage of von Willebrand factor.

  2010cites this paper
• An autoantibody epitope comprising residues R660, Y661, and Y665 in the ADAMTS13 spacer domain identifies a binding site for the A2 domain of VWF.

  2010cites this paper
• The ADAMTS13 metalloprotease domain: roles of subsites in enzyme activity and specificity.

  2010cites this paper
• Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura

  2010cites this paper
• Identification of ADAMTS13 peptide sequences binding to von Willebrand factor.

  2010cites this paper
• Crystal structures of the noncatalytic domains of ADAMTS13 reveal multiple discontinuous exosites for von Willebrand factor

  2010cites this paper
• Essential role of the disintegrin-like domain in ADAMTS13 function.

  2009cites this paper
• The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3.

  2009cites this paper
• Three-dimensional domain architecture of the ADAM family proteinases.

  2009cites this paper
• Multi‐step binding of ADAMTS‐13 to von Willebrand factor

  2009cites this paper
• RTEs: lazy T-cell teenagers.

  2009cites this paper